• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

世界卫生组织东地中海区域的利什曼病。

Leishmaniasis in the World Health Organization Eastern Mediterranean Region.

机构信息

World Health Organization, Eastern Mediterranean Regional Office, Cairo, Egypt.

出版信息

Int J Antimicrob Agents. 2010 Nov;36 Suppl 1:S62-5. doi: 10.1016/j.ijantimicag.2010.06.023. Epub 2010 Aug 21.

DOI:10.1016/j.ijantimicag.2010.06.023
PMID:20728317
Abstract

Leishmaniasis represents a major public health problem in the Eastern Mediterranean Region (EMR) of the World Health Organization (WHO). Cutaneous and visceral leishmaniasis are mainly seen in 14 of the 22 countries of the region. In several of these countries outbreaks have an apparent tendency to occur at around 10-year intervals. In 2008, some 100000 new cases of cutaneous leishmaniasis were reported. Foci of zoonotic cutaneous leishmaniasis, caused by Leishmania major, occur in Afghanistan, Egypt, Iran, Iraq, Jordan, Libya, Morocco, Palestine, Pakistan, Saudi Arabia, Sudan, Syria, Tunisia and Yemen. Anthroponotic cutaneous leishmaniasis, caused by L. tropica, occurs in Afghanistan, Iran, Iraq, Morocco, Pakistan, Saudi Arabia, Syria and Yemen. Anthroponotic visceral leishmaniasis, caused by L. donovani, occurs mainly in Sudan and Somalia. Zoonotic visceral leishmaniasis, caused by L. infantum, occurs in most countries of the region. In order to address the problem of leishmaniasis in the EMR, WHO is supporting ministries of health through a strategic plan focusing on (a) training programme managers and health workers on diagnosis and case management; (b) establishing a harmonized regional surveillance system; (c) creating a regional network of experts; (d) promoting political commitment of national governments.

摘要

利什曼病是世界卫生组织(世卫组织)东地中海区域(东地中海区域)的一个主要公共卫生问题。在该区域的 22 个国家中,有 14 个国家主要出现皮肤利什曼病和内脏利什曼病。在其中一些国家,疫情每隔约 10 年就有明显的发生趋势。2008 年,报告了约 100000 例新的皮肤利什曼病病例。由利什曼原虫引起的动物源性皮肤利什曼病集中发生在阿富汗、埃及、伊朗、伊拉克、约旦、利比亚、摩洛哥、巴勒斯坦、巴基斯坦、沙特阿拉伯、苏丹、叙利亚、突尼斯和也门。由 L. tropica 引起的人际源性皮肤利什曼病发生在阿富汗、伊朗、伊拉克、摩洛哥、巴基斯坦、沙特阿拉伯、叙利亚和也门。由 L. donovani 引起的人际源性内脏利什曼病主要发生在苏丹和索马里。由 L. infantum 引起的动物源性内脏利什曼病发生在该区域的大多数国家。为了解决东地中海区域的利什曼病问题,世卫组织通过一项战略计划,支持各国卫生部,重点关注以下方面:(a) 培训方案管理人员和卫生工作者进行诊断和病例管理;(b) 建立一个协调的区域监测系统;(c) 建立一个区域专家网络;(d) 促进各国政府的政治承诺。

相似文献

1
Leishmaniasis in the World Health Organization Eastern Mediterranean Region.世界卫生组织东地中海区域的利什曼病。
Int J Antimicrob Agents. 2010 Nov;36 Suppl 1:S62-5. doi: 10.1016/j.ijantimicag.2010.06.023. Epub 2010 Aug 21.
2
Status of blood transfusion in World Health Organization-Eastern Mediterranean Region (WHO-EMR): Successes and challenges.世界卫生组织东地中海区域(WHO-EMR)的输血状况:成就与挑战。
Transfus Apher Sci. 2017 Jun;56(3):448-453. doi: 10.1016/j.transci.2017.04.003. Epub 2017 May 8.
3
Lymphatic filariasis in the Eastern Mediterranean Region: current status and prospects for elimination.东地中海区域的淋巴丝虫病:现状与消除前景
East Mediterr Health J. 2003 Jul;9(4):534-41.
4
[Status of the taxonomy of Leishmania from the Mediterranean basin].[地中海盆地利什曼原虫的分类学现状]
Parassitologia. 1984 Dec;26(3):289-97.
5
Fertility and family planning in the Arab region.阿拉伯地区的生育与计划生育
IPPF Med Bull. 1986 Feb;20(1):1-3.
6
[The malaria situation in the WHO eastern Mediterranean region].[世界卫生组织东地中海区域的疟疾情况]
Med Parazitol (Mosk). 2000 Apr-Jun(2):12-5.
7
Leishmaniasis in an era of conflict in the Middle East.中东冲突时期的利什曼病。
Vector Borne Zoonotic Dis. 2011 Mar;11(3):247-58. doi: 10.1089/vbz.2010.0068. Epub 2010 Sep 16.
8
Changes in tobacco use among 13-15-year-olds between 1999 and 2007: findings from the Eastern Mediterranean Region.1999 年至 2007 年间 13-15 岁青少年烟草使用情况的变化:来自东地中海区域的调查结果。
East Mediterr Health J. 2010 Mar;16(3):266-73.
9
Recent advances in research and control of malaria, leishmaniasis, trypanosomiasis and schistosomiasis.疟疾、利什曼病、锥虫病和血吸虫病研究与防控的最新进展
East Mediterr Health J. 2003 Jul;9(4):518-33.
10
Human leishmaniases: epidemiology and public health aspects.人类利什曼病:流行病学与公共卫生方面
World Health Stat Q. 1992;45(2-3):267-75.

引用本文的文献

1
Seroprevalence of Canine Leishmaniasis in Sheltered Dogs in Bushehr Province, Southwest of Iran during 2022-2023.2022 - 2023年伊朗西南部布什尔省收容所犬只的犬利什曼病血清流行率
Iran J Parasitol. 2025 Apr-Jun;20(2):280-288. doi: 10.18502/ijpa.v20i2.19047.
2
An inclusive assessment of apoptosis mechanisms in species: A narrative literature review.物种凋亡机制的综合评估:一篇叙述性文献综述
Curr Res Parasitol Vector Borne Dis. 2025 Apr 17;7:100260. doi: 10.1016/j.crpvbd.2025.100260. eCollection 2025.
3
The burden of cutaneous leishmaniasis in Libya (2019-2022): Epidemiological insights and treatment practices.
利比亚皮肤利什曼病负担(2019 - 2022年):流行病学见解与治疗实践
Open Vet J. 2025 Apr;15(4):1685-1694. doi: 10.5455/OVJ.2025.v15.i4.20. Epub 2025 Apr 30.
4
A 2D Microfluidic Paper-Based Analytical Device for Diagnosis of Canine Visceral Leishmaniasis via Mass Spectrometry-Based Immunoassay.一种基于质谱免疫分析的二维微流控纸基分析装置用于犬内脏利什曼病的诊断
Anal Chem. 2025 Apr 8;97(13):7089-7097. doi: 10.1021/acs.analchem.4c05962. Epub 2025 Mar 24.
5
Genetic Diversity and Phylogenetic Study of Species in Iran by Multilocus Sequence Typing.基于多位点序列分型的伊朗物种遗传多样性与系统发育研究
Iran J Parasitol. 2024 Apr-Jun;19(2):171-182. doi: 10.18502/ijpa.v19i2.15853.
6
A Comprehensive Review of the Situation of Visceral Leishmaniasis Vectors in Iran.伊朗内脏利什曼病病媒情况的综合综述
J Arthropod Borne Dis. 2024 Mar 31;18(1):1-11. doi: 10.18502/jad.v18i1.15667. eCollection 2024 Mar.
7
Prediction of preventive behaviors of cutaneous leishmaniasis in the endemic areas of northwest Iran: an application of BASNEF model.伊朗西北部流行地区皮肤利什曼病预防行为的预测:BASNEF 模型的应用。
Sci Rep. 2024 Jun 15;14(1):13824. doi: 10.1038/s41598-024-64600-9.
8
Characterization of bacteria expectorated during forced salivation of the Phlebotomus papatasi: A neglected component of sand fly infectious inoculums.在强迫唾液分泌法采集白蛉时对所采集细菌的特征分析:白蛉感染接种物中被忽视的组成部分。
PLoS Negl Trop Dis. 2024 May 21;18(5):e0012165. doi: 10.1371/journal.pntd.0012165. eCollection 2024 May.
9
Clinical and laboratory characterization of cutaneous leishmaniasis in Chinese migrant workers returned from Iraq.从伊拉克返回的中国农民工的皮肤利什曼病的临床和实验室特征。
PLoS Negl Trop Dis. 2024 Mar 4;18(3):e0012006. doi: 10.1371/journal.pntd.0012006. eCollection 2024 Mar.
10
Field Efficacy of Topical Nano-Liposomal Amphotericin B (Sina Ampholeish®) Alone or in Combination with Glucantime® and Cryotherapy on Human Cutaneous Leishmaniasis.局部应用纳米脂质体两性霉素B(Sina Ampholeish®)单独或与戊烷脒(Glucantime®)及冷冻疗法联合治疗人类皮肤利什曼病的现场疗效
Iran J Parasitol. 2023 Oct-Dec;18(4):419-426. doi: 10.18502/ijpa.v18i4.14241.